- Home
- Publications
- Publication Search
- Publication Details
Title
Anti‐fibrotic mechanisms of angiotensin AT
2
‐receptor stimulation
Authors
Keywords
-
Journal
Acta Physiologica
Volume -, Issue -, Pages e13280
Publisher
Wiley
Online
2019-04-08
DOI
10.1111/apha.13280
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of protein phosphatase involvement in the AT 2 receptor-induced activation of endothelial nitric oxide synthase
- (2018) A. Augusto Peluso et al. CLINICAL SCIENCE
- VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease
- (2018) Shaney Barratt et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PDGF in organ fibrosis
- (2018) Barbara Mara Klinkhammer et al. MOLECULAR ASPECTS OF MEDICINE
- The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury
- (2018) Anandharajan Rathinasabapathy et al. Frontiers in Physiology
- Torilin Inhibits Inflammation by Limiting TAK1-Mediated MAP Kinase and NF-κB Activation
- (2017) Mehari Endale et al. MEDIATORS OF INFLAMMATION
- PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics
- (2017) Hua-Zhong Ying et al. Molecular Medicine Reports
- Structural basis for selectivity and diversity in angiotensin II receptors
- (2017) Haitao Zhang et al. NATURE
- Effect of Compound 21, a Selective Angiotensin II Type 2 Receptor Agonist, in a Murine Xenograft Model of Dupuytren Disease
- (2017) Jessica Chisholm et al. PLASTIC AND RECONSTRUCTIVE SURGERY
- Anti-fibrotic effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence
- (2017) Peter Sandner et al. RESPIRATORY MEDICINE
- Angiotensin receptors in Dupuytren’s disease: a target for pharmacological treatment?
- (2017) Christopher Stephen et al. Journal of Plastic Surgery and Hand Surgery
- Anti-fibrotic Potential of AT2 Receptor Agonists
- (2017) Yan Wang et al. Frontiers in Pharmacology
- The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis
- (2016) Bryna S. M. Chow et al. DIABETOLOGIA
- Angiotensin II Type 2–Receptor Agonist C21 Reduces Proteinuria and Oxidative Stress in Kidney of High-Salt–Fed Obese Zucker RatsNovelty and Significance
- (2016) Sanket N. Patel et al. HYPERTENSION
- Fibroblast growth factors and pulmonary fibrosis: it's more complex than it sounds
- (2016) Kevin K Kim et al. JOURNAL OF PATHOLOGY
- TGF-β: the master regulator of fibrosis
- (2016) Xiao-ming Meng et al. Nature Reviews Nephrology
- Angiotensin II Type 2 Receptor Decreases Transforming Growth Factor-β Type II Receptor Expression and Function in Human Renal Proximal Tubule Cells
- (2016) Hui-Lin Guo et al. PLoS One
- Strategies to overcome the hurdles to treat fibrosis, a major unmet clinical need
- (2016) Jagdeep Nanchahal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Attenuation of ligand-induced activation of angiotensin II type 1 receptor signaling by the type 2 receptor via protein kinase C
- (2016) Takayuki Inuzuka et al. Scientific Reports
- Selective activation of angiotensin AT2receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis
- (2015) E Bruce et al. BRITISH JOURNAL OF PHARMACOLOGY
- AT2R Agonist, Compound 21, Is Reno-Protective Against Type 1 Diabetic Nephropathy
- (2015) C. Koulis et al. HYPERTENSION
- A Nonpeptide Angiotensin II Type 2 Receptor Agonist Prevents Renal Inflammation in Early Diabetes
- (2015) Luis C. Matavelli et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Metalloproteinases: A parade of functions in matrix biology and an outlook for the future
- (2015) Suneel S. Apte et al. MATRIX BIOLOGY
- Diverse functions of matrix metalloproteinases during fibrosis
- (2014) M. Giannandrea et al. Disease Models & Mechanisms
- Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis
- (2014) Bryna S. Man Chow et al. KIDNEY INTERNATIONAL
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discovery and Characterization of Alamandine
- (2013) Roberto Queiroga Lautner et al. CIRCULATION RESEARCH
- Angiotensin Type 2 Receptor Stimulation Ameliorates Left Ventricular Fibrosis and Dysfunction via Regulation of Tissue Inhibitor of Matrix Metalloproteinase 1/Matrix Metalloproteinase 9 Axis and Transforming Growth Factor β1 in the Rat Heart
- (2013) Dilyara Lauer et al. HYPERTENSION
- Direct Angiotensin II Type 2 Receptor Stimulation in N ω -Nitro- l -Arginine-Methyl Ester–Induced Hypertension
- (2012) Ludovit Paulis et al. HYPERTENSION
- Pulmonary Hypertension as a Prognostic Indicator at the Initial Evaluation in Idiopathic Pulmonary Fibrosis
- (2012) Motohiro Kimura et al. RESPIRATION
- Angiotensin Type 2 Receptor Agonist Compound 21 Reduces Vascular Injury and Myocardial Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats
- (2011) Asia Rehman et al. HYPERTENSION
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
- Chronic kidney disease
- (2011) Andrew S Levey et al. LANCET
- Pirfenidone
- (2011) Luca Richeldi et al. NATURE REVIEWS DRUG DISCOVERY
- Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism
- (2011) J. P. Habashi et al. SCIENCE
- Direct Angiotensin II Type 2 Receptor Stimulation Acts Anti-Inflammatory Through Epoxyeicosatrienoic Acid and Inhibition of Nuclear Factor κB
- (2010) Franziska Rompe et al. HYPERTENSION
- Angiotensin AT 2 Receptor Stimulation Inhibits Early Renal Inflammation in Renovascular Hypertension
- (2010) Luis C. Matavelli et al. HYPERTENSION
- Tumor necrosis factor alpha induces LIF expression through ERK1/2 activation in mammary epithelial cells
- (2010) Carolina Schere Levy et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage
- (2009) Paolo Gelosa et al. JOURNAL OF HYPERTENSION
- The angiotensin II type 2 receptor in cardiovascular disease
- (2009) Catherine A Lemarié et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Angiotensin II type 2 receptor deficiency aggravates renal injury and reduces survival in chronic kidney disease in mice
- (2009) Ralf A. Benndorf et al. KIDNEY INTERNATIONAL
- Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis
- (2008) Barbara Ulmasov et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaque
- (2007) Abhijit Dandapat et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cellular and molecular mechanisms of fibrosis
- (2007) TA Wynn JOURNAL OF PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now